p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1

Huda H Al-Khalaf1, Dilek Colak, Maher Al-Saif

  • 1Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Plos One
|July 30, 2011
PubMed
Abstract

Insights

The tumor suppressor p16(INK4a) controls cyclin D1 and E2F1 expression by stabilizing their mRNAs via AUF1 regulation. This reveals p16(INK4a) as a key regulator of cell cycle, transcription, and apoptosis.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • The cyclin-D/CDK4,6/p16(INK4a)/pRB/E2F pathway is crucial for cell cycle regulation and frequently disrupted in cancer.
  • The exact roles and interactions of pathway members, particularly p16(INK4a), remain incompletely understood.

Purpose of the Study:

  • To elucidate the precise function of p16(INK4a) in regulating the expression of key cell cycle and transcription factors.
  • To investigate the molecular mechanisms underlying p16(INK4a)-mediated control of gene expression and apoptosis.

Main Methods:

  • Utilized human and mouse cell lines for experiments.
  • Employed mRNA stabilization assays, RNA immunoprecipitation (RIP), RT-PCR, and siRNA-mediated gene silencing.
  • Conducted genome-wide gene expression microarray analysis and apoptosis assays.

Main Results:

  • Demonstrated that p16(INK4a) positively controls cyclin D1 and E2F1 expression by stabilizing their mRNAs through negative regulation of AUF1.
  • Confirmed AUF1 binding to cyclin D1 and E2F1 mRNAs and showed that AUF1 downregulation increases gene expression.
  • Identified p16(INK4a)-dependent regulation of numerous genes, including those in AUF1 and E2F1 regulons, and showed E2F1 mediates p16-dependent apoptosis induction.

Conclusions:

  • p16(INK4a) functions not only as a cell cycle inhibitor but also as a modulator of transcription and apoptosis.
  • These effects are mediated through the regulation of major transcription regulators AUF1 and E2F1, impacting mRNA stability and gene expression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.